You only have to look to the recent reports of individual impacted by large-scale compounding to realise the dangers posed. Recent Developments In December 2024, Vivani Medical Inc., a pioneering biopharmaceutical company, declared the initiation of its first-in-human clinical trial, LIBERATE-1 at two centers in Australia for investigating the safety, tolerability and complete pharmacokinetic profile of a miniature, GLP-1 (exenatide) implant through the NPM-115 clinical program
With a strong focus on affordability and accessibility, we ensure that families, clinics, and hospitals receive the best products for their healthcare requirements
Choose the volume that makes your target measurement land on a round number of units
In parallel, personalized therapeutic strategies based on individual metabolic profiles, such as hyperglycemic status or age-related metabolic alterations, may help optimize treatment efficacy
Focus on: Adequate protein consumption : Aim for sufficient protein based on individual needs (the UK Reference Nutrient Intake is approximately 0.75g per kilogram of body weight daily, though requirements may be higher during weight loss)
